Guadeloupe vs Russia: Lung cancer death rates
Guadeloupe
6.22 deaths per 100,000 people
in 2016
Russia
6.18 deaths per 100,000 people
in 2019
Guadeloupe rank
63rd
Russia rank
64th
Lung cancer death rates over time
- Guadeloupe
- Russia
How they compare
Guadeloupe currently reports 6.22 deaths per 100,000 people against 6.18 deaths per 100,000 people in Russia, a difference of 0.04 deaths per 100,000 people.
The two have swapped places 3 times across 18 shared years of data; in 1981 it was Russia ahead.
Guadeloupe ranks 63rd and Russia ranks 64th of 111 countries.
Russia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Guadeloupe | Russia | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 2.54 deaths per 100,000 people | 7.19 deaths per 100,000 people | 4.65 deaths per 100,000 people | Russia |
| 2000s | 5.16 deaths per 100,000 people | 6.43 deaths per 100,000 people | 1.27 deaths per 100,000 people | Russia |
| 2010s | 4.98 deaths per 100,000 people | 6.28 deaths per 100,000 people | 1.3 deaths per 100,000 people | Russia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher lung cancer death rates, Guadeloupe or Russia?
- Guadeloupe, at 6.22 deaths per 100,000 people against 6.18 deaths per 100,000 people in Russia as of 2016.
- What is the difference in lung cancer death rates between Guadeloupe and Russia?
- 0.04 deaths per 100,000 people, with Guadeloupe ahead.
- How many years of comparable data are there for Guadeloupe and Russia?
- 18 years are reported by both, from 1981 to 2016.
- How do Guadeloupe and Russia rank globally for lung cancer death rates?
- Guadeloupe ranks 63rd and Russia ranks 64th of 111 countries.
- Where does this data come from?
- WHO Mortality Database (2025) – with minor processing by Our World in Data, published as Lung cancer death rates. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported deaths from trachea, bronchus, lung cancers in females in those aged all ages per 100,000 people.